Aridis Pharmaceuticals Inc. Stock News

If you're making a penny stocks watchlist right now, check these three out The post Are These Top Penny Stocks Worth Buying Right Now? appeared first on Penny Stocks to Buy, Picks, News and Informatio

Aridis Pharmaceuticals Inc. (NASDAQ:ARDS) traded at $2.78 at close of the session on Tuesday, 12/21/21, made an upward move of 9.45% on its previous days price. Looking at the stock we see that its previous close was $2.54 and the beta (5Y monthly) reads 0.11 with the days price range being $2.64 $4.34. In Investors Take Advantage Of 9.45% Gain In Aridis Pharmaceuticals Inc. (NASDAQ: ARDS) Read More »

Gainers Reliance Global Group, Inc. (NASDAQ: RELI ) surged 126% to $6.91 after gaining around 6% on Monday. Biofrontera Inc. (NASDAQ: BFRI ) climbed 71.4% to $13.06 after gaining over 7% on Monday. Biofrontera recently announced the first subject has been enrolled in the Phase 2b study to evaluate the safety and efficacy of Ameluz in combination with the red-light lamp BF-RhodoLED for acne. Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS ) jumped 36% to $3.4550 after the company reported pan-coronavirus monoclonal antibody cocktail that retains effectiveness against the omicron variant, other covid-19 variants, SARS, MERS, and the common cold human coronaviruses. Petros Pharmaceuticals, Inc. (NASDAQ: PTPI ) shares climbed 33.8% to $4.55. Evofem Biosciences, Inc. (NASDAQ: EVFM ) rose 24.1% to $0.46. The companys CEO Saundra L Pelletier bought 135,000 shares at an average price of $0.38 per share. Quantum-Si incorporated (NASDAQ: QSI ) gained 23.7% to $7.83. IsoPlexis Corporation (NASDAQ: ISO ) jumped 22.2% to $5.99.

Aridis Pharmaceuticals has a new cocktail, and it may be the ticket out of the omicron variant. Here''s why ARDS stock is worth watching.

Aridis Pharmaceuticals Inc. (NASDAQ:ARDS) has a beta value of 0.18 and has seen 23.19 million shares traded in the recent trading session. The company, currently valued at $33.05M, closed the recent trade at $3.20 per share which meant it gained $0.66 on the day or 25.98% during that session. The ARDS stock price is -164.69% Shares In Aridis Pharmaceuticals Inc. (ARDS) -58.15% Down, YTD Read More »

NEW YORK , Dec. 21, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for QNRX, ARDS, BFRI, SAVA, and ERJ. Full story available on Benzinga.com

Making a penny stocks watchlist today? Check these three out The post Best Penny Stocks to Buy as 2021 Ends?

Aridis Pharmaceuticals Inc (NASDAQ: ARDS) stock is surging after announcing encouraging preclinical data for pan coronavirus fully human monoclonal antibody (mAb) cocktail AR-701. The data show that

The stock price of Aridis Pharmaceuticals Inc (NASDAQ: ARDS) increased by over 105% pre-market today. This is why it happened.

Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) saw a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 5,100 shares, a decrease of 67.1% from the October 31st total of 15,500 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average trading []

ARDS, CNNE, EXK, GP, and IFF have been added to the Zacks Rank #5 (Strong Sell) List on November 15, 2021.

Aridis Pharmaceuticals (NASDAQ:ARDS) had its price objective cut by Northland Securities from $22.00 to $10.00 in a report released on Thursday morning, The Fly reports. They currently have an outperform rating on the stock. ARDS has been the subject of several other research reports. Zacks Investment Research downgraded shares of Aridis Pharmaceuticals from a buy []

Aridis Pharmaceuticals (NASDAQ:ARDS) had its target price decreased by Northland Securities from $22.00 to $10.00 in a report issued on Thursday, The Fly reports. Northland Securities currently has an outperform rating on the stock. ARDS has been the subject of several other research reports. Zacks Investment Research downgraded shares of Aridis Pharmaceuticals from a buy []